The Worldwide Hereditary Angioedema Industry is Projected to Reach $3.9 Billion by 2027 - ResearchAndMarkets.com

DUBLIN--()--The "Hereditary Angioedema: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The global market for Hereditary Angioedema estimated at US$2.3 Billion in the year 2020, is projected to reach a revised size of US$3.9 Billion by 2027, growing at a CAGR of 7.7% over the analysis period 2020-2027.

C1 Esterase Inhibitors, one of the segments analyzed in the report, is projected to record a 8.3% CAGR and reach US$1.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Selective Bradykinin B2 Receptor Antagonists segment is readjusted to a revised 6.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $666 Million, While China is Forecast to Grow at 7.1% CAGR

The Hereditary Angioedema market in the U.S. is estimated at US$666 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$676.4 Million by the year 2027 trailing a CAGR of 7.1% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.8% and 6.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.9% CAGR.

Kallikrein Inhibitors Segment to Record 8.9% CAGR

In the global Kallikrein Inhibitors segment, USA, Canada, Japan, China and Europe will drive the 8.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$261.7 Million in the year 2020 will reach a projected size of US$478.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

Select Competitors (Total 46 Featured) -

  • BioCryst Pharmaceuticals, Inc.
  • CSL Ltd.
  • iBio, Inc.
  • Ionis Pharmaceuticals, Inc.
  • Pharming Group NV
  • Shire PLC

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Hereditary Angioedema - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/koibh1

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900